The Role of Sugammadex in the JSA Airway Management Guideline：Does Induction of Anesthesia Become Safer by Using Sugammadex?

DOI Web Site 14 References Open Access

Bibliographic Information

Other Title
  • JSA気道管理ガイドラインにおけるスガマデクスの意義─麻酔導入はスガマデクスの存在で安全になったか─

Search this article

Description

<p>Sugammadex restores neuromuscular contraction by encapsulating rocuronium molecules inside its structure within the plasma, decreasing plasma rocuronium concentrations, and then decreasing rocuronium concentrations at the neuromuscular junction. The JSA airway guideline recommends administering 16 mg/kg sugammadex in cannot intubate/cannot ventilate situations during anesthesia induction with rocuronium. However, many case reports suggest the usefulness of much smaller doses of sugammadex for managing difficult airway situations. I discuss the advantages of using muscle relaxant during anesthesia induction and potential mechanisms for the usefulness of sugammadex for avoiding disaster in “cannot intubate/cannot ventilate” situations.</p>

Journal

References(14)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top